Protective Effect of Pemafibrate Treatment against Diabetic Retinopathy in Spontaneously Diabetic Torii Fatty Rats-Reference-Cited by-同舟云学术

Protective Effect of Pemafibrate Treatment against Diabetic Retinopathy in Spontaneously Diabetic Torii Fatty Rats

Published:2024-03-27 Issue:3 Volume:47 Page:713-722
ISSN:0918-6158
Container-title:Biological and Pharmaceutical Bulletin
language:en
Short-container-title:Biological & Pharmaceutical Bulletin

Author:

Tanaka Yoshiaki¹,Takagi Rina¹,Mitou Shingen¹,Shimmura Machiko¹,Hasegawa Tetsuya¹,Amarume Jota²,Shinohara Masami³,Kageyama Yasushi³,Sasase Tomohiko⁴,Ohta Takeshi⁵,Muramatsu Shin-ichi⁶,Kakehashi Akihiro¹,Kaburaki Toshikatsu¹

Affiliation:

1. Department of Ophthalmology, Jichi Medical University, Saitama Medical Center

2. Medical Affairs Department, Kowa Company, Ltd.

3. Tokyo Animal & Diet Department, CLEA Japan, Inc.

4. Biological/Pharmacological Research Laboratories, Central Pharmaceutical Research Institute, Japan Tobacco Inc.

5. Laboratory of Animal Physiology and Functional Anatomy, Graduate School of Agriculture, Kyoto University

6. Division of Neurological Gene Therapy, Center for Open Innovation, Jichi Medical University

Publisher

Pharmaceutical Society of Japan

Link

https://www.jstage.jst.go.jp/article/bpb/47/3/47_b23-00872/_pdf

Reference46 articles.

1. 1) Yau JW, Rogers SL, Kawasaki R, et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care, 35, 556–564 (2012).

2. 2) Teo ZL, Tham YC, Yu M, Chee ML, Rim TH, Cheung N, Bikbov MM, Wang YX, Tang Y, Lu Y, Wong IY, Ting DSW, Tan GSW, Jonas JB, Sabanayagam C, Wong TY, Cheng CY. Global prevalence of diabetic retinopathy and projection of burden through 2045: systematic review and meta-analysis. Ophthalmology, 128, 1580–1591 (2021).

3. 3) Ogurtsova K, da Rocha Fernandes JD, Huang Y, Linnenkamp U, Guariguata L, Cho NH, Cavan D, Shaw JE, Makaroff LE. IDF diabetes atlas: global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res. Clin. Pract., 128, 40–50 (2017).

4. 4) Leasher JL, Bourne RR, Flaxman SR, Jonas JB, Keeffe J, Naidoo K, Pesudovs K, Price H, White RA, Wong TY, Resnikoff S, Taylor HR. Global estimates on the number of people blind or visually impaired by diabetic retinopathy: a meta-analysis from 1990 to 2010. Diabetes Care, 39, 1643–1649 (2016).

5. 5) Hammes HP. Optimal treatment of diabetic retinopathy. Ther. Adv. Endocrinol. Metab., 4, 61–71 (2013).